年龄校正全基因组测序端粒长度在特发性肺纤维化中的表现
本研究利用MESA和COPDGene两个队列(n=9940)构建年龄校正的全基因组测序端粒长度(WGS-TL)列线图,并在肺纤维化基金会患者登记(PFF-PR)的825例特发性肺纤维化(IPF)患者中评估其识别端粒相关资格变异(TRQV)及生存区分能力。结果显示,IPF患者中年龄校正WGS-TL低于第10百分位者占28%,高于MESA(5%)和COPDGene(10%);该指标识别TRQV的AUC为0.66,优于原始WGS-TL的0.62,且与更短的无移植生存期相关(HR=1.35),但未改善超越临床变量的生存区分。
要点
- 年龄校正WGS-TL可识别IPF中端粒病理性缩短者,识别TRQV的AUC为0.66。
- IPF患者中年龄校正WGS-TL低于第10百分位者占28%,显著高于对照队列。
- 年龄校正WGS-TL低于第10百分位与更短3年无移植生存期相关(HR=1.35),但未优于临床变量。
核心结论
- 年龄校正WGS-TL可识别IPF中端粒病理性缩短的患者,适度提高TRQV检出,并与生存相关。
研究设计与样本
- 利用MESA和COPDGene两个队列(n=9940)构建年龄校正WGS-TL列线图,并在PFF-PR的825例IPF患者中评估诊断与生存区分性能。
主要发现
- IPF患者中年龄校正WGS-TL低于第10百分位者占28%,高于MESA的5%和COPDGene的10%。
- 年龄校正WGS-TL低于第10百分位识别TRQV的AUC为0.66(95%CI 0.60-0.73),优于原始WGS-TL的0.62(95%CI 0.56-0.69)。
- 在年龄校正和原始WGS-TL阈值下,特异性(0.74-0.99)均高于敏感性(0.10-0.58)。
- 年龄校正WGS-TL低于第10百分位与更短3年无移植生存期相关(HR=1.35,95%CI 1.05-1.74),但未改善超越临床变量的生存区分。
关键数值与推荐
- 年龄校正WGS-TL低于第10百分位定义为异常缩短,在IPF中占28%。
- 识别TRQV的AUC:年龄校正WGS-TL为0.66(95%CI 0.60-0.73),原始WGS-TL为0.62(95%CI 0.56-0.69)。
- 年龄校正WGS-TL低于第10百分位与3年无移植生存期相关HR=1.35(95%CI 1.05-1.74)。
临床怎么用
- 年龄校正WGS-TL可作为识别IPF患者端粒病理性缩短的辅助工具,但敏感性较低,需结合临床综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Whole genome sequencing-estimated telomere length (WGS-TL) correlates with directly measured peripheral blood telomere length. However, raw WGS-TL does not account for normal age-related telomere attrition to identify patients with idiopathic pulmonary fibrosis (IPF) with pathologically short telomeres. OBJECTIVES: To determine utility of age-adjusted WGS-TL to identify adults with telomere-related qualifying variants (TRQVs) and whether it associates with survival. METHODS: WGS-TL from two samples of community-dwelling adults (MESA) and people who smoke cigarettes (COPDGene) were used to construct an age-adjusted WGS-TL nomogram (n = 9940) using linear regression models that regressed on raw WGS-TL and adjusted for chronologic age. Using this nomogram, age-adjusted WGS-TL was generated in IPF cases from the Pulmonary Fibrosis Foundation Patient Registry (PFF-PR) (n = 825) to determine diagnostic performance characteristics for identifying TRQV and survival discrimination. MEASUREMENTS AND MAIN RESULTS: There was a higher proportion of IPF patients from the PFF-PR with abnormally short age-adjusted WGS-TL <10th percentile (28%) compared with MESA (5%) or COPDGene (10%). Among IPF patients, age-adjusted WGS-TL <10th percentile outperformed raw WGS-TL <10th percentile at discriminating TRQV (area under the receiver operating curve = 0.66 [95% CI, 0.60-0.73] vs 0.62 [95% CI, 0.56-0.69]). At both the shorter age-adjusted and raw WGS-TL thresholds, specificity (0.74-0.99) was higher than sensitivity (0.10-0.58). Age-adjusted WGS-TL below the 10th percentile was associated with shorter 3-year transplant-free survival (HR, 1.35 [95% CI, 1.05-1.74]) but did not improve survival discrimination over clinical variables alone. CONCLUSIONS: Age-adjusted WGS-TL enables identification of IPF patients with pathologically short telomeres, modestly improves detection of TRQV, and associates with survival.
引用
- Kim JS, Receveur B, Zhang D, et al. Performance of age-adjusted whole genome sequencing telomere length in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2026. PMID: 42261270. doi:10.1093/ajrccm/aamag259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。